Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Recurrence 1Optic Nerve Glioma 1Oligodendroglioma 1Medulloblastoma 1Lymphoma 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Radiotherapy 5Melphalan 4Filgrastim 4Busulfan 4Topotecan 3Methylprednisolone 3Cyclophosphamide 3Carboplatin 3Vorinostat 2Voriconazole 2Thiotepa 2Therapeutics 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Itraconazole 2Flow Cytometry 2Early Intervention, Educational 2Antilymphocyte Serum 2Amplified Fragment Length Polymorphism Analysis 2trioctyl phosphine oxide 1sargramostim 1liposomal amphotericin B 1ispinesib 1imetelstat 1gallium nitrate 1fludarabine phosphate 1exatecan 1etoposide phosphate 1becatecarin 1alvocidib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dendritic Cell Sarcoma, Interdigitating × exatecan × CNS × Clear all
NCT00004212 2012-05-16

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Daiichi Sankyo

Phase 1 Completed
CNSLymphoidSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Lymphoma, Medulloblastoma, Oligodendroglioma, Recurrence, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡